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1. Introduction 
Drug absorption from the gastrointestinal tract is a complex process and is subject to many physiological variables.  
Gastric emptying time (GET) is one of them which is the time taken for stomach contents to be passed into the duodenum 
and in humans it’s normally averages 2-3 hrs through the major absorption zone, i.e., stomach and upper part of the 
intestine. The short GET can result in incomplete drug release from the drug delivery system leading to reduced efficacy of 
the administered dose.[1]
 
In order to overcome such limitations many scientist contributes their valuable support to make an ideal oral drug 
delivery system for those drugs that have narrow absorption window and poor bioavailability. One of the main hurdles is 
the poor gastric residence time (GRT) of drug. The average time required for a dosage unit to traverse the GIT is 3–4 h, 
although slight variations exist among various dosage forms.[2]
 
The gastro retentive floating drug delivery system can remain in the gastric region for several hours via float on 
the gastric contents and hence significantly prolong the gastric residence time of drugs. The pharmaceutical dosage form 
with gastro retentive properties would enable an extended absorption phase of those drugs with narrow absorption window. 
After oral administration, such a dosage form would be retained in the stomach and release the drug there in a controlled 
and prolonged manner, so that the drug could be supplied continuously to its absorption sites in the upper gastrointestinal 
tract.[3-4]  
 
2. Experimental 
2.1 Materials 
      Famotidine was received as a gift sample from Themis Laboratories, Mumbai. Rosin and Psyllium husk were 
received as a gift sample from Zim laboratories, India. Guar Gum was received as a gift sample from Colorcon asia pacific, 
Goa, India.  SBC, Talc and Magnesium Stearate were purchased from S.D. Fine-Chem Ltd., India. All the other chemicals 
used were of analytical grade. 
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2.2 Methods 
      Calibration curves of FMT were determined in 0.1 M HCl at l = 266 nm (R = 0.9932), using a UV-Visible 
spectrophotometer (Shimadzu, Japan). The calibration curve in 0.1 M HCl was used for dissolution studies.  
2.3 Preparation of Famotidine gastroretentive tablets (FMTGR) 
      FMTGR tablets were prepared according to the composition of optimized batches (Table I) FMTGR tablets (300 
mg) were prepared by the direct compression method. Initially, all ingredients were sieved through sieve no. 80, weighed 
and mixed for 10 min. Famotidine was mixed with Guar Gum (GG), Rosin and Psyllium husk alone and in combination. 
Sodium Bicarbonate (SBC), Talc and MCC were added. Finally, the magnesium stearate was added as a lubricant and 
mixed for additional 2–3 min as shown in table 1. Tablets were compressed on a tablet machine (10 stations, Cadmach 
Machinery, Mumbai. India) fitted with a 10mm circular shaped standard concave punch.  
 
Table 1:  Famotidine and Guar gum alone and in combinations with various other polymers 
 (Formulations G1- G8) 
 
Ingredient (mg) BATCH CODE 
G1 G2 G3 G4 G5 G6 G7 G8 
Famotidine 40 40 40 40 40 40 40 40 
Guar Gum 60 80 100 120 100 80 100 80 
Psyllium Husk - - - - 20 40   
Rosin       20 40 
Sodium Bicarbonate 50 50 50 50 50 50 50 50 
Mg Stearate 3 3 3 3 3 3 3 3 
Talc 6 6 6 6 6 6 6 6 
MCC 141 121 101 81 81 81 81 81 
Total weight  300 300 300 300 300 300 300 300 
 
2.4 Evaluation of Tablets [5-8]
 
Sustained release floating matrix tablets were developed using release retarding, gel forming polymers like Guar 
Gum, Rosin, and Psyllium Husk (PH) etc and gas forming agent like NaHCO3 and evaluated for following parameters. 
Formulations G1 to G4 prepared with guar gum started floating after 126 sec, 143 sec, 164 sec and 176 sec and 
remained buoyant for more than 12h till they were completely eroded except formulation G1. On the other hand, 
formulation G5-G6 prepared with combination of guar gum and PH showed decrease in floating lag time 105 sec and 102 
sec and increased floating duration (>12h). This might be due to high hydrophilicity of polymers PH and GG maintains the 
integrity of the tablets for longer duration by reducing the effect of erosion thus resulting in increase in floating time. Result 
obtained with batches prepared from guar gum and Rosin was similar to FLT of Formulations G1 to G4.  
2.5 In Vitro Drug Release Study 
 
The present study was aimed to make the formulation remain in the stomach for longer period of time, gastro 
retentive dosage form was designed, to release the drug in controlled and sustained manner in gastric fluid. 
 
Table 2: Dissolution data of FMT and Guar gum tablets alone and in combination of various polymers 
 
Time (hr) G1 G2 G3 G4 G5 G6 G7 G8 
2 54.48±2.1 34.60±4.7 23.6±3.61 19. 39±1.87 37.91±2.56 43.72±2.78 33.89±2.92 38.54±2.51 
4 65.74±1.67 49.48±3.34 40.81±2.02 25.33±2.68 61.66±2.47 67.57±3.89 45.83±3.56 58.38±2.82 
6 81.05±1.95 63.57±3.02 57.57±2.27 33.6±2.61 72.15±3.15 86.47±2.68 63.64±2.74 75.59±3.49 
8 100.90±1.6 78.3±2.05 72.52±3.78 39.98±3.49 87.43±2.31 100.2±3.21 82.54±2.18 99.5±3.33 
10 - 99.56±0.55 83.68±3.99 51.02±3.59 99.93±0.69 - 99.81±2.17 - 
12 - - 99.21±1.91 67.33±2.63 - - - - 
All values are mean ± SD, (n = 3) 
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2.6 In-Vitro Dissolution Studies of Formulations G1 to G8 
 
 
Fig. 1a: Effect of guar gum conc. on in vitro release of Famotidine (Mean ± SD, n=3) 
 
 
  
 
Fig. 1b: Effect of psyllium husk conc. in combination with guar gum on in vitro release of Famotidine  
(Mean ± SD, n=3) 
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Fig. 1c: Effect of Rosin conc. in combination with guar gum on in vitro release of Famotidine (Mean ± SD, n=3) 
 
The in vitro drug release study revealed that formulations G1, G2, G3 and G4 containing 20% , 26.67%, 33% and 
40% guar gum, respectively releases drug 100% for 8 h, 99.36 for 10 h, 83.68 and 67.33 for 12h. Total buoyancy was 4 to 
12h and tablet integrity was poor for guar gum formulations. Formulations G1 underwent swelling and erosion, resulting in 
faster drug release. Formulation G2 containing 26.67% of GG was sufficient to sustain the drug release for 12 h on 
increasing the quantity of GG up to 40%, the release of the drug was too slow and only 67.33% of drug was released. It was 
observed that when the polymer concentration was increased, the drug release rate was decreased. In vitro release data for 
batches G1, G2, G3 and G4 showed that the release of FMT decreased with the increase in concentration of guar gum 
showing initial burst release in acidic medium (pH 1.2) during first 2 hours such that 54% in formulation G1. Famotidine 
and guar gum in a ratio 1:2.5 can reduced initial burst release (G3) with CPR 100 % /12 hour and less floating lag time with 
buoyancy for 12 hrs. But guar gum in a ratio 1:3 can reduce initial burst release (G4 with CPR 67 % /12 hour).
 
This clearly 
indicated that guar gum is able to sustain the drug release in the acidic medium itself therefore, overall extent of drug 
release at the end of 8 hour. Faster release of the drug from the hydrophilic matrix was probably due to faster dissolution o f 
the water soluble drug (FMT) from the core and its diffusion out of the matrix forming the pores for entry of solvent 
molecules and also may be due to alkaline nature of FMT. The release kinetics data from table 3 showed that batch GG 
followed nearly Korsemeyer peppas kinetics with maximum regression coefficient of 0.998 and non fickian diffusion 
mechanism (n>0.5). It was observed that penetration of water into the guar gum based sustained release tablets resulted into 
formulation of gel layer on the tablet surface that swelled up initially and controlled the release thereafter. Formulations 
G5-G8 composed of Guar Gum and various polymers like psyllium husk (formulations G5 and G6), Rosin (formulations 
G7 and G8),   Formulations G1, G6 and G8 showed 100% drug release for 8 h. Formulations G2, G5 and G7 for 10 h and 
Formulations G3 showed 100% and G4 showed 67% drug release for 12 h as  shown in Fig. 1. This variation was 
considered to be due to different polymer types and their concentrations. The in vitro drug release from the matrices 
containing hydrophilic polymers at various conc. was shown in Fig.1. The influence of Guar Gum -Psyllium Husk ratio on 
the release of Famotidine from floating tablets in 0.1N HCl (pH 1.2) at 37±0.5
º
C was shown in Fig. 2. Effect of different 
concentrations of Psyllium husk on in vitro release of Famotidine was studied. As the conc. of Psyllium husk increases, 
initial burst drug release as well as drug release in the later hours increases. Drug associated with the surface of tablet 
matrix could have also contributed to the initial burst release. The gel like networks surrounding these matrices upon 
contact with aqueous media would produce strong surface barriers that would effectively reduce the burst drug release in 
case of various earlier mentioned polymers in combination with guar gum in a ratio 1:5.
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Fig.1b and 1c demonstrate the effect of guar gum on the release of Famotidine from dosage form containing guar 
gum and other various polymers. Guar gum provides slow release in the stomach. Guar gum has the most homogeneous gel 
structure and there are very few channels through which the drug may diffuse hence guar gum have the slowest release rate 
in buffer of pH 1.2. Formulations without guar gum exhibited a much higher burst effect likely due to the fact that guar 
gum when contacted with water it would swell and hold water inside its microgel network. This particular property may 
partially be responsible for the retarded release of drug from the floating drug delivery system. The initial burst drug 
dissolution normally seen in tablets is primarily due to the quick penetration of water into pore of polymer matrix and 
diffusion of the drug through these pores prior to complete gel formation.
 
17% of sodium bicarbonate (of total tablet weight) was incorporated in the Floating Matrix Tablets produced an 
optimized batch. Sodium bicarbonate generates CO2 in the presence of a dissolution medium. The generated gas is trapped 
and protected within the gel formed by hydration of polymer, thus decreasing the density of the tablet. As the density of the 
tablet falls below 1g/cm
3
, the tablet becomes buoyant.
 
The swelling studies revealed that formulations G1, G2, G3 and G4 containing 20%, 24%, 33% and 40 % Guar 
Gum, respectively, were able to show maximum swelling for 5 to 8 h. Formulations G4 and G5  showed greater than 200% 
swelling after 8 h and 6 h respectively. Formulations G2 and G3 showed greater than 150% swelling after 5 h and 
Remaining Formulations showed less than 150% swelling after 5 h. This variation in release of drug was considered to be 
due to different polymer types and their concentrations.  
 
Table 3: Kinetic modeling of drug release for formulations G1-G8 
Batch Code 
R
2
 Value 
Best Fit 
Models Zero order 
First 
Order 
Higuchi Hixon Crowell Korsmeyer Peppas 
n 
value 
G1 0.903 0.970 0.989 0.805 0.946 0.430 First Order 
G2 0.865 0.9924 0.9920 0.984 0.989 0.424 First Order 
G3 0.995 0.984 0.997 0.977 0.975 0.508 Zero order 
G4 0.963 0.977 0.972 0.976 0.97 0.594 KP 
G5 0.973 0.957 0.978 0.867 0.996 0.716 KP 
G6 0.948 0.987 0.995 0.875 0.998 0.603 KP 
G7 0.982 0.674 0.961 0.870 0.973 0.678 Zero order 
G8 0.976 0.997 0.975 0.891 0.990 0.668 First Order 
 
In vitro matrix tablet release data were fitted to Korsmeyer Peppas release model and interpretation of release 
exponent values (n) enlightens in understanding the release mechanism from the dosage form. The release exponent values 
thus obtained thus obtained were ranged from 0.6 to 0.86. formulations G4, G5 and G6 exhibited Korsmeyer Peppas release 
model and followed anomalous (Non Fickian Transport) diffusion mechanism with a value ranging between 0.603 to 0.86 
(Table 3). Formulations G3 and G7 showed as highest R
2
 values for zero order kinetics indicating the FMT release from 
these floating tablets were by both diffusion and erosion.
 
Formulations G1, G2 and G8 followed first order drug release 
kinetics exhibiting values of n in a 0.43 and 0.424 for G1 and G2 while 0.668 was for G8.  
Formulation G3 was selected as a most promising formulations for further study depending on its excellent 
floating behavior (very short floating lag time and prolonged floating duration), sustained drug release characteristics, 
swelling study, and zero order drug release kinetics. Thus taking into consideration the goal of the work of achieving a 
compromise between excellent floating behavior (very short floating lag time and prolonged floating duration) and 
sustained drug release characteristics, formula G3 was chosen for further studies. 
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